Teva launches cash and shares bid for Mylan

By

Sharecast News | 21 Apr, 2015

Teva Pharmaceuticals has announced a cash and shares bid for US rival Mylan at $82 per share.

--More to follow--

Last news

London close: Stocks end turbulent week in the red
Broker tips: Flutter Entertainment, Premier Foods
Director dealings: AstraZeneca CEO ups stake
US open: Stocks lower following Powell comments, retails sales numbers
FTSE 100 movers: Pharma stocks take a hit; Land Securities rallies